Medication-info.com Search Menu

Ticlopidine: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Boxed warning
Strength:
250 mg
Drug class:
Active ingredient:
Similar drugs:

Source: FDA drug labeling via NLM DailyMed · About this document

Patient information: uses, side effects, how to take - Ticlopidine

Who Should Not Take Ticlopidine Hydrochloride Tablets?

Contact your doctor immediately and do not take ticlopidine hydrochloride tablets if:

  • you have an allergic reaction to ticlopidine hydrochloride tablets
  • you have a blood disorder or a serious bleeding problem, such as a bleeding stomach ulcer
  • you have previously been told you had TTP or aplastic anemia
  • you have severe liver disease or other liver problems
  • you are pregnant or you are planning to become pregnant
  • you are breast-feeding

Manufactured In Israel By:

TEVA PHARMACEUTICAL IND. LTD.

Jerusalem, 91010, Israel

Manufactured For:

TEVA PHARMACEUTICALS USA

Sellersville, PA 18960

Rev. H 2/2012

About this document

Source: FDA drug labeling via NLM DailyMed · Application number: ANDA 075149 · View the label on DailyMed

Revision date stated in the text: February 2012

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Ticlopidine

Rx or OTC
Prescription (Rx)?
  • This drug is available only with a prescription from a licensed healthcare provider.
  • Rx
Boxed warning Yes – this drug has a boxed warning (also called a black box warning), the strongest warning of the FDA.
Drug class Platelet Aggregation Inhibitor
Active ingredient Ticlopidine hydrochloride 250 mg
Dosage form Tablet, film coated
Route Oral
Marketing status not in the current FDA NDC Directory
Company (applicant) TEVA
FDA approval ANDA 075149Abbreviated New Drug Application (ANDA) – generic drug Approved August 20, 1999
Packages (NDC)
Package
250 mg – 1 in 1 bottle NDC 68151-0079-0

Source: FDA drug labeling via NLM DailyMed, data as of October 31, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.